These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 20670763)

  • 1. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells.
    Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP
    J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates.
    Weber B; Scherman J; Emmert MY; Gruenenfelder J; Verbeek R; Bracher M; Black M; Kortsmit J; Franz T; Schoenauer R; Baumgartner L; Brokopp C; Agarkova I; Wolint P; Zund G; Falk V; Zilla P; Hoerstrup SP
    Eur Heart J; 2011 Nov; 32(22):2830-40. PubMed ID: 21415068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans-apical versus surgical implantation of autologous ovine tissue-engineered heart valves.
    Dijkman PE; Driessen-Mol A; de Heer LM; Kluin J; van Herwerden LA; Odermatt B; Baaijens FP; Hoerstrup SP
    J Heart Valve Dis; 2012 Sep; 21(5):670-8. PubMed ID: 23167234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter aortic valve implantation using anatomically oriented, marrow stromal cell-based, stented, tissue-engineered heart valves: technical considerations and implications for translational cell-based heart valve concepts.
    Emmert MY; Weber B; Behr L; Sammut S; Frauenfelder T; Wolint P; Scherman J; Bettex D; Grünenfelder J; Falk V; Hoerstrup SP
    Eur J Cardiothorac Surg; 2014 Jan; 45(1):61-8. PubMed ID: 23657551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.
    Hoerstrup SP; Kadner A; Melnitchouk S; Trojan A; Eid K; Tracy J; Sodian R; Visjager JF; Kolb SA; Grunenfelder J; Zund G; Turina MI
    Circulation; 2002 Sep; 106(12 Suppl 1):I143-50. PubMed ID: 12354724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From stem cells to viable autologous semilunar heart valve.
    Sutherland FW; Perry TE; Yu Y; Sherwood MC; Rabkin E; Masuda Y; Garcia GA; McLellan DL; Engelmayr GC; Sacks MS; Schoen FJ; Mayer JE
    Circulation; 2005 May; 111(21):2783-91. PubMed ID: 15927990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
    Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
    Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling.
    Rabkin E; Hoerstrup SP; Aikawa M; Mayer JE; Schoen FJ
    J Heart Valve Dis; 2002 May; 11(3):308-14; discussion 314. PubMed ID: 12056720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell-based transcatheter aortic valve implantation: first experiences in a pre-clinical model.
    Emmert MY; Weber B; Wolint P; Behr L; Sammut S; Frauenfelder T; Frese L; Scherman J; Brokopp CE; Templin C; Grünenfelder J; Zünd G; Falk V; Hoerstrup SP
    JACC Cardiovasc Interv; 2012 Aug; 5(8):874-83. PubMed ID: 22917460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic flexure and laminar flow synergistically accelerate mesenchymal stem cell-mediated engineered tissue formation: Implications for engineered heart valve tissues.
    Engelmayr GC; Sales VL; Mayer JE; Sacks MS
    Biomaterials; 2006 Dec; 27(36):6083-95. PubMed ID: 16930686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Living autologous heart valves engineered from human prenatally harvested progenitors.
    Schmidt D; Mol A; Breymann C; Achermann J; Odermatt B; Gössi M; Neuenschwander S; Prêtre R; Genoni M; Zund G; Hoerstrup SP
    Circulation; 2006 Jul; 114(1 Suppl):I125-31. PubMed ID: 16820561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
    Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
    Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?
    Vincentelli A; Wautot F; Juthier F; Fouquet O; Corseaux D; Marechaux S; Le Tourneau T; Fabre O; Susen S; Van Belle E; Mouquet F; Decoene C; Prat A; Jude B
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):424-32. PubMed ID: 17662783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous tissue-engineered pulmonary valved stent implantation.
    Lutter G; Metzner A; Jahnke T; Bombien R; Boldt J; Iino K; Cremer J; Stock UA
    Ann Thorac Surg; 2010 Jan; 89(1):259-63. PubMed ID: 20103248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model.
    Flanagan TC; Sachweh JS; Frese J; Schnöring H; Gronloh N; Koch S; Tolba RH; Schmitz-Rode T; Jockenhoevel S
    Tissue Eng Part A; 2009 Oct; 15(10):2965-76. PubMed ID: 19320544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A xenogeneic acellularized matrix for heart valve tissue engineering: in vivo study in a sheep model].
    Leyh R; Wilhelmi M; Haverich A; Mertsching H
    Z Kardiol; 2003 Nov; 92(11):938-46. PubMed ID: 14634763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source.
    Schmidt D; Achermann J; Odermatt B; Breymann C; Mol A; Genoni M; Zund G; Hoerstrup SP
    Circulation; 2007 Sep; 116(11 Suppl):I64-70. PubMed ID: 17846327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional living trileaflet heart valves grown in vitro.
    Hoerstrup SP; Sodian R; Daebritz S; Wang J; Bacha EA; Martin DP; Moran AM; Guleserian KJ; Sperling JS; Kaushal S; Vacanti JP; Schoen FJ; Mayer JE
    Circulation; 2000 Nov; 102(19 Suppl 3):III44-9. PubMed ID: 11082361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart valve tissue engineering.
    Neuenschwander S; Hoerstrup SP
    Transpl Immunol; 2004 Apr; 12(3-4):359-65. PubMed ID: 15157927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.
    Weber B; Zeisberger SM; Hoerstrup SP
    Placenta; 2011 Oct; 32 Suppl 4():S316-9. PubMed ID: 21575988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.